Cost-utility analysis of treating mild stage normal tension glaucoma by surgery in China: a decision-analytic Markov model

Table 4 The results of Probabilistic sensitivity analysis of different treatment strategies

Treatment strategy	Average costs	Incremental cost	Average Efficacy	Incremental QALYs	ICUR, US$/QALYs
Treatment strategy	person, $	Incremental cost	QALYs	Incremental QALYs	ICUR, US$/QALYs
Treatment all by medication
Positive Treatment	3973.28		6.58
Traditional Treatment	1898.85	2074.43	6.43	0.15	13,829.53
50% surgery rate
Positive Treatment	2765.48		6.58
Traditional Treatment	1898.82	866.66	6.43	0.15	5777.73
25% surgery rate
Positive Treatment	3370.94		6.58
Traditional Treatment	1899.24	1471.70	6.43	0.15	9811.33
25% surgery rate + 5 times the cost of surgery
Positive Treatment	3560.96		6.58
Traditional Treatment	1975.79	1585.17	6.43	0.15	10,567.80
25% surgery rate + 10 times the cost of surgery
Positive Treatment	3892.81		6.58
Traditional Treatment	1975.79	1917.02	6.43	0.15	12,780.13
50% surgery rate + 5 times the cost of surgery
Positive Treatment	3234.54		6.58
Traditional Treatment	1975.79	1258.75	6.43	0.15	8391.67
50% surgery rate + 10 times the cost of surgery
Positive Treatment	3898.25		6.58
Traditional Treatment	1975.79	1922.46	6.43	0.15	12,816.40

ISSN: 1478-7547